HealthQuant Associates

HealthQuant Associates applies quantitative, systematic strategies to the healthcare and life sciences sectors. Based on the firm's name and limited available descriptors, the model likely incorporates statistical analysis of clinical trial data, FDA regulatory patterns, and reimbursement flows to generate investment signals. The precise mix of long/short, market-neutral, or directional strategies has not been publicly detailed by the firm.

The principals of HealthQuant Associates have not been identified through public record, regulatory filings, or financial press. No named founders, portfolio managers, or investment committee members appear in standard industry databases or firm communications. The leadership structure remains private.

The firm's capital structure — whether it manages third-party investor assets, operates as a family office vehicle, or trades proprietary capital — has not been publicly disclosed. No SEC registration or ADV filing was located to clarify its regulatory status or client base.

No public AUM figure or performance track record is available for HealthQuant Associates. The firm has not published audited returns, appeared in investor databases with verified asset totals, or been cited by institutional allocators in publicly available meeting minutes.

The firm's physical location has not been confirmed. No office address appears on a firm website, in LinkedIn records, or in state business registrations that could be tied definitively to an active investment operation under this name.